GSK Depemokimab accepted for review by EMA for use in asthma with type 2 inflammation, CRSwNP Ruchika Sharma29 Jan 2025 2:30 PM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for...
GSK Shingrix new prefilled syringe presentation accepted for review by EMA Ruchika Sharma28 Jan 2025 10:15 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe...
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Ruchika Sharma21 Jan 2025 1:30 PM ISTLondon: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
Pfizer to sell USD 3 billion stake in Haleon Ruchika Sharma15 Jan 2025 2:30 PM ISTPfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 billion) in the British...
GSK Shingrix new prefilled syringe presentation accepted for review by USFDA Ruchika Sharma11 Jan 2025 11:30 AM ISTGSK plc has announced that the US Food and Drug Administration (USFDA) has accepted for review the regulatory application of a prefilled syringe...
GSK bone cancer treatment gets USFDA Breakthrough Therapy Designation Ruchika Sharma7 Jan 2025 3:00 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation for GSK5764227...
GSK Nucala approved in China for treatment of adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma4 Jan 2025 1:00 PM ISTLondon: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a monoclonal antibody...
CDSCO Panel Approves GSK Protocol Amendment proposal for Belrestotug and Dostarlimab study Dr. Divya Colin27 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
Jemperli bags USFDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer: GSK Ruchika Sharma16 Dec 2024 1:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Jemperli...
Blenrep combo accepted for priority review in China in relapsed/refractory multiple myeloma: GSK Ruchika Sharma11 Dec 2024 1:30 PM ISTLondon: GSK plc has announced that the National Medical Products Administration (NMPA) of China has accepted for review a new drug application...
USFDA accepts GSK submission for use of Nucala in COPD Ruchika Sharma11 Dec 2024 11:30 AM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study to support the...
